An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs-Reference-Cited by-同舟云学术

An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs

Published:2016-01-04 Issue:6 Volume:5 Page:e1123368
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Hirayama Masatoshi,Tomita Yusuke,Yuno Akira,Tsukamoto Hirotake,Senju Satoru,Imamura Yuya,Sayem Mohammad Abu,Irie Atsushi,Yoshitake Yoshihiro,Fukuma Daiki,Shinohara Masanori,Hamada Akinobu,Jono Hirofumi,Yuba Eiji,Kono Kenji,Yoshida Koji,Tsunoda Takuya,Nakayama Hideki,Nishimura Yasuharu

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2015.1123368

Reference60 articles.

1. Cancer immunotherapy using novel tumor‐associated antigenic peptides identified by genome‐wide cDNA microarray analyses

2. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck

3. IMP3 expression is correlated with histologic grade of lung adenocarcinoma

4. The Oncofetal Protein IMP3

5. Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in cancer immunotherapy: Application of nano-therapeutic systems;Journal of Drug Delivery Science and Technology;2024-01

2. IGF2BP3 expression in pan-cancer: A bioinformatics-based study of its prognostic relevance and immunological role;2023-06-12

3. Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review);International Journal of Oncology;2023-05-05

4. The Expression of Insulin-Like Growth Factor II Messenger RNA-Binding Protein 3 Upregulated in Intradural Extramedullary Schwannomas;Spine Surgery and Related Research;2023-01-27

5. Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms;Pharmaceutics;2022-07-11